Rosenheck, Michael
Obaitan, Itegbemie
Sharma, Neil
Al-Haddad, Mohammad
DeWitt, John M. https://orcid.org/0000-0003-3835-4464
,
Rosenheck, M.
Obaitan, I.
Rajagopalan, V.
Montrose, J.
Baydoun, H.
Al Qady, A.
Hajj-Ali, A.
Batarseh, M. G.
Javed, Z.
Dahbour, A. S.
Pamidimukkala, U.
Momoh, O.
Zelt, S.
Perkins, A.
Sharma, N.
Al-Haddad, M. A.
DeWitt, J. M.
Article History
Received: 30 August 2025
Accepted: 12 December 2025
First Online: 5 January 2026
Declarations
:
: Michael Rosenheck, MD; Itegbemie Obaitan, MBBS, MPH; Jonathan Montrose, DO; Hussein Baydoun, MD; Ahmed Al Qady, MD; Adel Hajj-Ali, MD; Vikram Rajagopalan, MBBS; Olufunke Momoh, NP; Christina Zelt, MSN, RN, CRC; Mina Batarseh, MD; Zoya Javed, MBBS; Anthony Perkins, MSc; Aladdin Dahbour, MD; Ujwala Pamidimukkala declare that they have no conflicts of interest or financial ties to disclose. Neil Sharma, MD: consultant for Boston Scientific, Olympus America, Medtronic, and Steris. Mohammad Al-Haddad, MD, MSc, FACG: consultant for Boston Scientific and Interpace Diagnostics; grant support from Amplified Sciences. John M. DeWitt, MD, FACG, FASGE: consultant for Boston Scientific and Olympus America. All authors have reviewed and approved the final draft for submission.